Detalhe da pesquisa
1.
Circulating growth factor concentrations and breast cancer risk: a nested case-control study of IGF-1, IGFBP-3, and breast cancer in a family-based cohort.
Breast Cancer Res
; 22(1): 109, 2020 10 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33092613
2.
A phase 1b dose expansion study of the pan-class I PI3K inhibitor buparlisib (BKM120) plus carboplatin and paclitaxel in PTEN deficient tumors and with dose intensified carboplatin and paclitaxel.
Invest New Drugs
; 35(6): 742-750, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28281183
3.
Altered salivary microbiota associated with high-sugar beverage consumption.
Sci Rep
; 14(1): 13386, 2024 06 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38862651
4.
Germline immunomodulatory expression quantitative trait loci (ieQTLs) associated with immune-related toxicity from checkpoint inhibition.
Eur J Cancer
; 189: 112923, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37301715
5.
Kinase Insert Domain Receptor Q472H Pathogenic Germline Variant Impacts Melanoma Tumor Growth and Patient Treatment Outcomes.
Cancers (Basel)
; 16(1)2023 Dec 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38201446
6.
Elevated dietary carbohydrate and glycemic intake associate with an altered oral microbial ecosystem in two large U.S. cohorts.
Cancer Res Commun
; 2(12): 1558-1568, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36567732
7.
Phase II clinical and immune correlate study of adjuvant nivolumab plus ipilimumab for high-risk resected melanoma.
J Immunother Cancer
; 10(11)2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36450385
8.
Parallel phase Ib studies of two schedules of buparlisib (BKM120) plus carboplatin and paclitaxel (q21 days or q28 days) for patients with advanced solid tumors.
Cancer Chemother Pharmacol
; 75(4): 747-55, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25672916